Invention Grant
- Patent Title: Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
-
Application No.: US16845539Application Date: 2020-04-10
-
Publication No.: US11702411B2Publication Date: 2023-07-18
- Inventor: Jie Jack Li , Elena S. Koltun , Adrian Liam Gill , Andreas Buckl , Walter Won , Naing Aay , Kevin Mellem , Christos Tzitzilonis , Ashutosh Jogalekar , James Joseph Cregg
- Applicant: Revolution Medicines, Inc.
- Applicant Address: US CA Redwood City
- Assignee: REVOLUTION MEDICINES, INC.
- Current Assignee: REVOLUTION MEDICINES, INC.
- Current Assignee Address: US CA Redwood City
- Agency: Cooley LLP
- Main IPC: C07D407/14
- IPC: C07D407/14 ; C07D401/04 ; C07D401/14
Abstract:
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Public/Granted literature
- US20200339552A1 PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS Public/Granted day:2020-10-29
Information query
